Home » BARR FILES AN AMENDED TENDER OFFER FOR PLIVA D.D. WITH HANFA
BARR FILES AN AMENDED TENDER OFFER FOR PLIVA D.D. WITH HANFA
September 8, 2006
Barr Pharmaceuticals, Inc. announced that its European subsidiary has filed an amended tender offer with the Croatian Financial Services Supervisory Agency to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. Under Croatian law, unless HANFA publicly discloses the amount upon approval of the
amended bid, Barr is prohibited from discussing the amount and other specifics
of its amended bid until HANFA approval is received and Barr publishes the terms
of its amended bid in the Croatian media.
Barr
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct